Date published: 2026-1-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADAMTS-19 Activators

A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of zinc-dependent extracellular enzymes that play a crucial role in a myriad of biological processes. These enzymes are active participants in the cleavage, restructuring, and maintenance of the extracellular matrix (ECM), which is a vital component of tissues and organs. ADAMTS-19, like other members of the ADAMTS family, is involved in the proteolytic processing of various substrates within the ECM. Its signaling mechanisms are embedded within a web of regulatory pathways that include cytokine networks, growth factors, and other enzymes. These pathways modulate ADAMTS-19 expression levels and enzymatic activity, implicating it in ECM remodeling, cell migration, and the modulation of other cellular behaviors. Factors like epigenetic regulation, substrate availability, and endogenous inhibitors further add layers of complexity to the regulation of ADAMTS-19 activity.

ADAMTS-19 activators are aimed at understanding molecules that can specifically or indirectly modulate the activity of ADAMTS-19. While several types of molecules are being investigated for their role in activating or facilitating ADAMTS-19 function, these range from small organic compounds to larger biological molecules. Small molecules like HDAC inhibitors and TGF-β inhibitors have been researched for their impact on the epigenetic and transcriptional regulation of ADAMTS-19, respectively. Others like MMP inhibitors can indirectly contribute by preserving the availability of substrates in the ECM for ADAMTS-19. Activators may also interact with ADAMTS-19 through various mechanisms such as inhibition of opposing pathways or through complex signaling cascades. These molecules provide valuable insights into the intricate layers of regulation governing ADAMTS-19 activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

HDAC Inhibitors may influence the epigenetic regulation of ADAMTS-19 gene expression.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

By inhibiting TGF-β, these could potentially upregulate ADAMTS-19 expression if TGF-β is a suppressor.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA Methyltransferase Inhibitors could affect the methylation status of the ADAMTS-19 gene, potentially increasing its expression.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$34.00
$74.00
$270.00
$114.00
34
(1)

May activate ADAMTS-19 by reducing oxidative stress conditions that otherwise inhibit it.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

NF-κB Inhibitors could potentially upregulate ADAMTS-19 by suppressing NF-κB signaling, if NF-κB acts as a suppressor.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

Wnt Pathway Inhibitors may influence ADAMTS-19 by affecting Wnt signaling, which is known to be involved in ECM remodeling.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

PKC Inhibitors could influence various signaling pathways that may indirectly activate ADAMTS-19.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

JAK/STAT Inhibitors may affect the cytokine signaling that influences ADAMTS-19 expression or activity.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

MEK Inhibitors could affect MAPK pathways that influence ADAMTS-19.

Cobalt(II) chloride

7646-79-9sc-252623
sc-252623A
5 g
100 g
$64.00
$176.00
7
(1)

HIF-1α Stabilizers could potentially influence the hypoxia-related activation or expression of ADAMTS-19.